
This phase zzso study determined the safety, zzso and recommended phase 2 dose zzso and schedule of zzso in combination with zzso Secondary objectives included assessment of clinical activity and zzso zzso 

Adults with advanced solid zzso adequate organ function and Eastern zzso Oncology Group performance status zzso zzso zzso 1 were zzso zzso oral zzso zzso zzso zzso was escalated in a zzso design with standard zzso dosing zzso zzso IV Days 1, 8, and 15 of zzso zzso During expansion, zzso zzso was combined with zzso zzso samples were collected on Day 15 zzso and 1, 2, 4 and zzso zzso zzso assessments were repeated every two zzso 

Between zzso and zzso 31 patients zzso zzso 11, breast zzso 6, zzso cell lung cancer zzso zzso 4, other zzso 10) were zzso zzso zzso zzso occurred in each zzso and included zzso zzso zzso zzso and zzso The zzso was declared as zzso zzso daily with standard zzso zzso Common grade 3/4 zzso at the zzso zzso zzso zzso zzso zzso and zzso zzso zzso Of 10 patients with measurable pancreatic cancer, three partial responses zzso were zzso two additional patients achieved objective responses zzso complete response zzso zzso zzso partial response zzso zzso suggested no change in zzso of either drug in zzso 

Administration of zzso at its full zzso dose of zzso daily in combination with standard zzso dosing zzso zzso IV Days 1, 8, and 15 every 28 zzso was zzso Though most zzso were zzso the addition of zzso may increase zzso zzso Future studies of this combination will require monitoring to maintain dose and zzso 

